BIOGEN for BIOGEN
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, PET scan coverage and reimbursement, and dementia care Appropriations on Alzheimers screening and diagnosis Discussions regarding H.R. 1319, the American Rescue Plan Discussions regarding Zero co-payment for biosimilars Discussions regarding Biogen's Healthy Climate, Healthy Lives initiative Issues related to the CHANGE Act Vial size wastage issue
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| STEPHANIE A. DYSON | — |
| JOHN RAYMOND GIBSON | — |
| MICHELLE MATHY | — |
| CHUCK SHIH | — |
| CAROLINE TUCKER | — |
Medicare/Medicaid MMM
Discussions regarding Medicaid 340B drug discount program Biosimilars shared savings demonstration model in Part B AMP Cap
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY DEMSKE | — |
| CHRISTINA HOCHUL | — |
| MICHELLE MATHY | — |
Budget/Appropriations BUD
Discussions regarding H.Con.Res. 11, FY2021 Budget Resolution
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| STEPHANIE A. DYSON | — |
Pharmacy PHA
H.R.3/S.2543, Elijah E. Cummings Lower Drug Costs Now Act, discussions regarding support to increase Part B biosimilar payments from ASP +6% to ASP +8% of the reference product Advocate against inclusion of drug pricing as pay-fors in any COVID-19 relief package Oppose drug pricing proposals that include international procing index (IPI) or similar policies, Medicare drug negotiation, Medicare Part D redesign (including sections in H.R.3, S.2543, H.R.19. S.3129)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| STEPHANIE A. DYSON | — |
| MICHELLE MATHY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.